ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of LX1606 in Subjects With Symptomatic Carcinoid Syndrome Not Managed by Stable-Dose Octreotide Therapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00853047
Recruitment Status : Completed
First Posted : February 27, 2009
Last Update Posted : May 3, 2016
Sponsor:
Information provided by (Responsible Party):
Lexicon Pharmaceuticals

Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Completed
  Actual Primary Completion Date : June 2014
  Actual Study Completion Date : June 2014
  Certification/Extension First Submitted : February 4, 2016

Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 March 27, 2017
May 5, 2017
2 March 5, 2018
April 2, 2018
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):